Results 71 to 80 of about 2,106,514 (153)

Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL-2 Inhibitors. [PDF]

Cancer Med
Schulze FJ, Shumilov E, Behringer A, Kerkhoff A, Eckhardt M, Bätker S, Maulhardt M, Lenz G, Pohlmann A.   +8 more
europepmc   +1 more source

Reply to Trela, B.A.; Guffroy, M.R. Comment on "AlAsmari et al. Venetoclax Induces Cardiotoxicity Through Modulation of Oxidative-Stress-Mediated Cardiac Inflammation and Apoptosis via NF-κB and BCL-2 Pathway. <i>Int. J. Mol. Sci.</i> 2022, <i>23</i>, 6260". [PDF]

Int J Mol Sci
AlAsmari AF, Alghamdi A, Ali N, Alasmari F.   +3 more
europepmc   +1 more source

Synthesis of bridged steroids. I. Steroids having a bridged bicyclo[3.2.1]octane ring system of the phyllocladene type.

Chemical and pharmaceutical bulletin, 1968
W. Nagata, M. Narisada
semanticscholar   +1 more source

Visible-light-mediated stereoselective construction of oxa-spiro bicyclohexanes via strain-release [2π + 2σ] cycloaddition. [PDF]

Sci Adv
Singh S, Kim C, Lee D, Kim D, Hong S.
europepmc   +1 more source

Selenium atom transfer enables selective bridged alkene-arylamine cycloaddition. [PDF]

Nat Commun
Hu J, Zhang K, Zhang J, Li D, Su Y, Chen S, He Q, Deng D, Zhang J, Wang G, Jing S.   +10 more
europepmc   +1 more source

Fixed-time treatment of elderly patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) using hypomethylating agents and venetoclax - a case series. [PDF]

Ann Hematol
Lindemann A, Göckel G, Garcia-Pardillos G.   +2 more
europepmc   +1 more source

Venetoclax combined with chidamide and decitabine successfully induced remission in relapsed/refractory classical Hodgkin lymphoma: a case report and literature review. [PDF]

Front Immunol
Jin X, Tang Y, Wu Y, Ji J.
europepmc   +1 more source

Safe Accelerated Venetoclax Escalation: a phase 1b study of obinutuzumab plus venetoclax with daily ramp-up in CLL. [PDF]

Blood Adv
Crombie JL, Ahn IE, Ren Y, Tyekucheva S, Carey C, Kniezewski M, Normilus S, Solomon S, Montegaard J, Kim AI, Merryman RW, Armand P, Fisher DC, Brown JR, Davids MS.   +14 more
europepmc   +1 more source

Long-term outcomes of azacitidine, venetoclax, and gilteritinib in newly diagnosed FLT3-mutated AML. [PDF]

Blood Adv
Short NJ, Kantarjian H, Daver N, Azevedo RS, Karrar O, DiNardo CD, Kadia T, Yilmaz M, Maroun M, Hachem M, Borthakur G, Issa GC, Shpall EJ, Popat U, Huang X, Qiao W, Nasr L, Macaron W, Abramova R, Garcia-Manero G, Konopleva M, Ravandi F.   +21 more
europepmc   +1 more source

Chiral benzo[2.2.1] α-hydroxyketones from a dirhodium(ii)/bisphosphine-catalyzed desymmetrization addition reaction. [PDF]

Chem Sci
Zhan S, Wang C, Duan L, Gu Z.
europepmc   +1 more source